(Q43891835)

27 November 2017

Tumor-specific transcriptional targeting of suicide gene therapy (English)

1 reference

27 November 2017

0 references

Qiao J

1

1 reference

27 November 2017

Doubrovin M

2

1 reference

27 November 2017

Sauter BV

3

1 reference

27 November 2017

Huang Y

4

1 reference

27 November 2017

Guo ZS

5

1 reference

27 November 2017

Balatoni J

6

1 reference

27 November 2017

Akhurst T

7

1 reference

27 November 2017

Blasberg RG

8

1 reference

27 November 2017

Tjuvajev JG

9

1 reference

27 November 2017

Chen SH

10

1 reference

27 November 2017

Woo SL

11

1 reference

27 November 2017

1 February 2002

1 reference

27 November 2017

1 reference

27 November 2017

9

1 reference

27 November 2017

168-175

1 reference

27 November 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3301618

27 November 2017

0 references

cites work

Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301618

Severe hepatic dysfunction after adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene and ganciclovir administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301618

Breast cancer selective gene expression and therapy mediated by recombinant adenoviruses containing the DF3/MUC1 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301618

Selective killing of AFP-positive hepatocellular carcinoma cells by adeno-associated virus transfer of the herpes simplex virus thymidine kinase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301618

Tumor cell-specific transgene expression prevents liver toxicity of the adeno-HSVtk/GCV approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301618

Tumor-specific gene expression in carcinoembryonic antigen--producing gastric cancer cells using adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301618

Adenovirus-mediated gene therapy of gastric carcinoma using cancer-specific gene expression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301618

Enhanced and specific gene expression via tissue-specific production of Cre recombinase using adenovirus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301618

GAL4-VP16 is an unusually potent transcriptional activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301618

Adenoviral vectors capable of replication improve the efficacy of HSVtk/GCV suicide gene therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301618

Restricted expression of an adenoviral vector encoding Fas ligand (CD95L) enhances safety for cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301618

Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesothelioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301618

Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with current malignant brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301618

In vitro and in vivo hepatoma cell-specific expression of a gene transferred with an adenoviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301618

Enhanced ganciclovir killing and bystander effect of human tumor cells transduced with a retroviral vector carrying a herpes simplex virus thymidine kinase gene mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301618

Isolation and characterization of cDNA clones encoding the human carcinoembryonic antigen reveal a highly conserved repeating structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301618

Characteristics of a human cell line transformed by DNA from human adenovirus type 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301618

Epithelial mouse mammary cell line exhibiting normal morphogenesis in vivo and functional differentiation in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301618

Cloning of the complete gene for carcinoembryonic antigen: analysis of its promoter indicates a region conveying cell type-specific expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301618

GAL4 activates gene expression in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301618

In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301618

Combination gene therapy for liver metastasis of colon carcinoma in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301618

Gene transfer and therapy with adenoviral vector in rats with diethylnitrosamine-induced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301618

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.GT.3301618

1 reference

Dimensions Publication ID

27 November 2017

0 references

1 reference